Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhikun Liu

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Gene|April 6, 2013
Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patientsQi Ling, Fengqin Dong, Lei Geng, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 22, 2020
Regulatory T Cell Therapy Following Liver TransplantationJiongjie Yu, Zhikun Liu, Changbiao Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 18, 2021
Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular CarcinomaZhikun Liu, Jiangwei Ye, Abid Ali Khan, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 14, 2023
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising roadYufeng Gu, Shengjun Xu, Zhengxin Wang, et al.
Clinical Laboratory|February 12, 2024
Tumor Promoting Effect of Long Non-Coding RNA RP11-556E13.1 and its Clinical Significance in Hepatocellular CarcinomaJie Li, Xun Qiu, Zhikun Liu, et al.
Journal of Medicinal Chemistry|September 28, 2023
Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and ApoptosisMeng Wang, Guoxiu Cao, Junjie Zhou, et al.
Journal of Medicinal Chemistry|April 17, 2026
Simultaneous Induction of Ferroptosis and Immunogenic Cell Death by TrxR-Targeted Pt(IV) Prodrugs for Chemoimmunotherapy of Triple-Negative Breast CancerGuimei Li, Juping Tang, Lang Wang, et al.
Colloids and Surfaces. B, Biointerfaces|December 31, 2020
Dual catalytic cascaded nanoplatform for photo/chemodynamic/starvation synergistic therapyDihai Gu, Zhikun Liu, Hongshuai Wu, et al.
Hepatology International|March 30, 2022
Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation studyZhikun Liu, Yuanpeng Liu, Wenhui Zhang, et al.
Journal of Inorganic Biochemistry|March 11, 2026
Multifunctional platinum(IV) complexes reverse cisplatin resistance in triple- negative breast cancer via ferroptosis and apoptosisGuoxiu Cao, Junjie Zhou, Yuhan Qian, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Gene|April 6, 2013
Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patientsQi Ling, Fengqin Dong, Lei Geng, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 22, 2020
Regulatory T Cell Therapy Following Liver TransplantationJiongjie Yu, Zhikun Liu, Changbiao Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 18, 2021
Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular CarcinomaZhikun Liu, Jiangwei Ye, Abid Ali Khan, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 14, 2023
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising roadYufeng Gu, Shengjun Xu, Zhengxin Wang, et al.
Clinical Laboratory|February 12, 2024
Tumor Promoting Effect of Long Non-Coding RNA RP11-556E13.1 and its Clinical Significance in Hepatocellular CarcinomaJie Li, Xun Qiu, Zhikun Liu, et al.
Journal of Medicinal Chemistry|September 28, 2023
Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and ApoptosisMeng Wang, Guoxiu Cao, Junjie Zhou, et al.
Journal of Medicinal Chemistry|April 17, 2026
Simultaneous Induction of Ferroptosis and Immunogenic Cell Death by TrxR-Targeted Pt(IV) Prodrugs for Chemoimmunotherapy of Triple-Negative Breast CancerGuimei Li, Juping Tang, Lang Wang, et al.
Colloids and Surfaces. B, Biointerfaces|December 31, 2020
Dual catalytic cascaded nanoplatform for photo/chemodynamic/starvation synergistic therapyDihai Gu, Zhikun Liu, Hongshuai Wu, et al.
Hepatology International|March 30, 2022
Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation studyZhikun Liu, Yuanpeng Liu, Wenhui Zhang, et al.
Journal of Inorganic Biochemistry|March 11, 2026
Multifunctional platinum(IV) complexes reverse cisplatin resistance in triple- negative breast cancer via ferroptosis and apoptosisGuoxiu Cao, Junjie Zhou, Yuhan Qian, et al.
Pageof 15